MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.New data from the ARCHER ...
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES VANCOUVER, BC / PERTH, AUSTRALIA / ACCESS Newswire / October 21, 2025 / Sarama Resources Ltd. ("Sarama" or the "Company") (ASX:SRR)(TSX-V:SWA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback